The Drugs Controller General of India (DCGI) on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above, official sources said on Tuesday.
While other mRNA vaccines require to be stored at sub-zero temperatures, Gennova's mRNA vaccine can be stored at 2-8 degrees, an official source told PTI.
The drug regulator has also approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions.
The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years and Gennova's two dose m-RNA vaccine for 18 years and above, official sources said.
Prakash Kumar Singh, director, Government and Regulatory Affairs at Serum Institute of India (SII) had submitted an application to DCGI in this regard on March 16, official sources had said. The expert panel, in its last meeting in April, had sought more data from the Pune-based firm over the application.
The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9.
The country began inoculating children aged 12-14 years from March 16. The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from February 2 last year.
The next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.
India launched vaccination for all people aged more than 45 years from April 1 last year. The government then decided to expand its vaccination drive by allowing everyone
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Catch Up Vaccination For Children; It Is Never Too Late US Approves Covid Vaccines For Children As Young As 6 Months "Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects Amazon Employee Greets Friend At Wedding, Dies Of Cardiac Arrest "Thousand Times Better...": Delhi Lt Governor's Surprise For AAP's Atishi Indian Student In US Accidentally Shoots Himself Dead While Celebrating Birthday AAP Appoints Punjab Minister Aman Arora As New President Of Its State Unit Man, 60, Shot Dead By 77-Year-Old In Paris McDonald's French Man Raped Daughter For Years, 'Offered' Her To Strangers, Jailed Track Latest News Live on NDTV.com and get news updates from India and around the world.